Triple
T2430989
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | NIDA Notes |
E52843
|
entity |
| Predicate | publisher |
P29
|
FINISHED |
| Object | NIDA |
E9512
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NIDA | Statement: [NIDA Notes, publisher, NIDA]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NIDA Context triple: [NIDA Notes, publisher, NIDA]
-
A.
NIDA International Program
NIDA International Program is a global initiative of the U.S. National Institute on Drug Abuse that fosters international collaboration in drug abuse research, training, and policy.
-
B.
National Institute on Drug Abuse
chosen
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
C.
NIDA Drug Supply Program
The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.
-
D.
NIDA Notes
NIDA Notes is a publication of the National Institute on Drug Abuse that reports on research findings and developments related to drug use, addiction, and their prevention and treatment.
-
E.
NIDA Division of Therapeutics and Medical Consequences
The NIDA Division of Therapeutics and Medical Consequences is a branch of the National Institute on Drug Abuse that oversees research and development of treatments and medical interventions related to substance use and its health impacts.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ab4959bcc0819083246f9fb10439e3 |
completed | March 6, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69abc9c767a88190b31cbccdce8e8982 |
completed | March 7, 2026, 6:46 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69af17864e9881909b32b70d55028016 |
completed | March 9, 2026, 6:55 p.m. |
Created at: March 6, 2026, 9:43 p.m.